Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.

Santos AA, Lopes CC, Ribeiro JR, Martins LR, Santos JC, Amorim IF, Gärtner F, Matos AJ.

BMC Vet Res. 2013 Jan 4;9:1. doi: 10.1186/1746-6148-9-1.

2.

Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.

Santos A, Lopes C, Marques RM, Amorim I, Ribeiro J, Frias C, Vicente C, Gärtner F, de Matos A.

Vet J. 2011 Jul;189(1):43-8. doi: 10.1016/j.tvjl.2010.05.023. Epub 2010 Jul 2.

PMID:
20598596
3.

Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.

Santos A, Lopes C, Frias C, Amorim I, Vicente C, Gärtner F, Matos Ad.

Vet J. 2011 Dec;190(3):396-402. doi: 10.1016/j.tvjl.2010.12.003. Epub 2011 Jan 26.

PMID:
21269852
4.

MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.

De Matos AJ, Lopes CC, Faustino AM, Carvalheira JG, Dos Santos MS, Rutteman GR, Gärtner Mde F.

Anticancer Res. 2006 May-Jun;26(3A):1821-6.

5.

Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.

Queiroga FL, Pérez-Alenza D, Silvan G, Peña L, Lopes CS, Illera JC.

Res Vet Sci. 2010 Dec;89(3):396-403. doi: 10.1016/j.rvsc.2010.03.016. Epub 2010 Apr 8.

PMID:
20381105
7.

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.

Zhang B, Cao X, Liu Y, Cao W, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X.

BMC Cancer. 2008 Mar 28;8:83. doi: 10.1186/1471-2407-8-83.

8.

Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.

Millanta F, Fratini F, Corazza M, Castagnaro M, Zappulli V, Poli A.

Res Vet Sci. 2002 Aug;73(1):45-51.

PMID:
12208106
9.

Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.

Santos AA, Lopes CC, Marques RM, Amorim IF, Gärtner MF, de Matos AJ.

Am J Vet Res. 2012 May;73(5):689-97. doi: 10.2460/ajvr.73.5.689.

PMID:
22533401
10.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

11.

Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.

Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M, Vascellari M, Castagnaro M, Lopparelli RM, Zancanella V, Granato A, Mutinelli F, Dacasto M.

J Comp Pathol. 2012 Nov;147(4):419-29. doi: 10.1016/j.jcpa.2012.01.011. Epub 2012 Apr 19.

PMID:
22520817
12.

Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.

Santos AA, Oliveira JT, Lopes CC, Amorim IF, Vicente CM, Gärtner FR, Matos AJ.

J Comp Pathol. 2010 Nov;143(4):268-75. doi: 10.1016/j.jcpa.2010.04.006. Epub 2010 Jun 8.

PMID:
20570280
13.

MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.

Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR.

Breast Cancer Res Treat. 2011 Jun;127(3):591-9. doi: 10.1007/s10549-010-1028-3. Epub 2010 Jul 11.

PMID:
20623333
14.

Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.

Pinho SS, Matos AJ, Lopes C, Marcos NT, Carvalheira J, Reis CA, Gärtner F.

BMC Cancer. 2007 Jul 6;7:124.

16.

Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.

Brun JL, Cortez A, Lesieur B, Uzan S, Rouzier R, Daraï E.

Oncol Rep. 2012 Apr;27(4):1049-57. doi: 10.3892/or.2011.1608. Epub 2011 Dec 22.

17.

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.

Clin Cancer Res. 2004 Nov 15;10(22):7621-8.

18.

Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.

Rakha EA, Tun M, Junainah E, Ellis IO, Green A.

J Clin Pathol. 2012 Aug;65(8):710-4. doi: 10.1136/jclinpath-2012-200710. Epub 2012 May 3.

PMID:
22554960
19.

The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.

Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD.

Vet Comp Oncol. 2009 Dec;7(4):230-5. doi: 10.1111/j.1476-5829.2009.00193.x.

PMID:
19891693
20.

Supplemental Content

Support Center